




Searching News Database: KV Pharmaceutical
HSMN NewsFeed - 11 Jun 2010
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
KV Pharmaceutical Company Announces New Board Members and Restructuring of Senior Executive Management
HSMN NewsFeed - 21 Sep 2009
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
Perrigo Acquires ANDA for Generic Version Duac(R) Gel From KV Pharmaceutical
HSMN NewsFeed - 11 Dec 2008
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
HSMN NewsFeed - 3 Jun 2008
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules
HSMN NewsFeed - 15 May 2008
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
HSMN NewsFeed - 18 Feb 2008
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
Paladin Labs & KV Pharmaceuticals Sign Distribution For Micro-K(R) Extencaps(R) Capsules
HSMN NewsFeed - 25 Oct 2007
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
KV Pharmaceutical Announces FDA Approval for Morphine ER 100 mg and 200 mg Tablets
HSMN NewsFeed - 30 Jul 2007
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
KV Pharmaceutical Announces U.S. Food and Drug Administration Approval of EvaMist(TM)
HSMN NewsFeed - 21 Jun 2007
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
HSMN NewsFeed - 18 May 2007
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed - 16 May 2007
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
KV Pharmaceutical Company Completes Acquisition of U.S. Rights to EvaMist(TM)
HSMN NewsFeed - 6 Mar 2007
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
Jury Finds in Favor of ETHEX/KV on All Claims Against KV Pharmaceutical and ETHEX Subsidiary
HSMN NewsFeed - 11 Jul 2006
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
Solvay Pharmaceuticals Settles Lawsuit Against Pseudo-Generic to CREON(R) MINIMICROSPHERES(R)
HSMN NewsFeed - 30 May 2006
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
Stiefel Laboratories Appoints Jim Loerop, Vice President U.S. Corporate Development
Additional items found! 28

Members Archive contains
28 additional stories matching:
KV Pharmaceutical
(Password required)
KV Pharmaceutical
(Password required)